In recent years, homocysteine (Hcy) has become known as an amino acid of significant clinical importance.
Normally, Hcy forms from the intracellular metabolism of methionine and is subsequently broken down by one of two pathways: remethylation or transsulfuration. In the remethylation pathway, a methyl group, from either N 5 -methyltetrahydrofolate or betaine, is transferred to Hcy to reform methionine. Alternatively, Hcy can enter the transsulfuration pathway, where it is broken down into cysteine (Cys) and ␣-ketobutyrate via the sequential actions of cystathionine-␤-synthase and ␥-cystathionase. 2 Alterations in these metabolic pathways may lead to hyperhomocysteinemia, which can contribute to the induction of cardiovascular disease in some humans. 3 A number of studies have implicated the kidney as a major site of Hcy metabolism.
1,2,4 -7 Although both pathways involved in the metabolism of Hcy (ie, transsulfuration and remethylation) are used by renal epithelial cells, 8 the transsulfuration route is the predominant means by which Hcy is degraded in these cells. 5, 6 Moreover, this degradation occurs primarily in the epithelial cells lining the proximal tubule. 5 Although our understanding of Hcy metabolism within proximal tubular cells is advancing, the mechanisms by which Hcy gains entry in the cytosolic compartments of these cells remain unclear.
Interestingly, proximal tubular cells are also the primary sites where inorganic mercury (Hg 2ϩ ) accumulates and exerts its toxic effects. Because of the strong electrophilic properties of Hg 2ϩ , mercuric ions are carried around in the plasma as conjugates of thiol-containing biomolecules. Extracellular thiols that have been implicated in the binding of Hg 2ϩ include Cys and glutathione (GSH). In fact, in vitro data from our laboratory indicate that mercuric conjugates of Cys, particularly in the form of 2-amino-3-(2-amino-2-carboxy-ethylsulfanylmercuricsulfanyl)propionic acid (Cys-S-Hg-S-Cys), are taken up at the luminal plasma membrane of proximal tubular cells by the heterodimeric amino acid transporter, system b 0,ϩ . 9 This transporter is comprised of a light chain subunit, b 0,ϩ AT and a heavy chain subunit, rBAT. 10, 11 It should be pointed out that system b 0,ϩ is the principal sodium-independent amino acid transporter involved in the luminal absorption of the amino acid cystine along the proximal tubule. 10 -14 Because of the structural homology between Cys-S-Hg-S-Cys and cystine (Cys-S-S-Cys), we proposed recently that Cys-S-Hg-S-Cys behaves as a molecular mimic of cystine at system b 0,ϩ . 9 Hcy is a thiol-containing amino acid and is a homologue of Cys. Thus one would expect this amino acid to form linear II coordinate covalent complexes with Hg 2ϩ . Indeed, our laboratory has shown indirectly that the mercuric conjugate of Hcy, 2-amino-4-(3-amino-3-carboxypropylsulfanylmercuricsulfanyl)butyric acid (Hcy-S-Hg-S-Hcy) is transported by proximal tubular cells. 15 When Hg 2ϩ was administered intravenously to rats as Hcy-SHg-S-Hcy, some of the administered Hg 2ϩ was taken up at the luminal plasma membrane of proximal tubular epithelial cells. 15 The mechanism(s) for this uptake has/ have not yet been defined. However, given that Hcy-SHg-S-Hcy is similar structurally to the disulfide amino acid homocystine (Hcy-S-S-Hcy), the participation of luminal amino acid transporters seems to be a logical possibility. Some support for this notion comes in part from in vitro data showing that the transport of Hcy and homocystine in the kidneys is mediated by a high-affinity transporter with a substrate specificity similar to that characterized for the cystine transporter, system b 0,ϩ . 16 Additional evidence from in vitro studies using retinal pigment epithelial cells indicates that Hcy is a substrate of system b 0,ϩ . 17 As homocystine and cystine are structural homologues, it is logical, therefore, to postulate that homocystine may be transported by the same amino acid transporter (ie, system b 0,ϩ ) that facilitates the uptake of cystine and the mercuric conjugate, Cys-S-Hg-S-Cys. Moreover, given the structural similarity between Cys-SHg-S-Cys and Hcy-S-Hg-S-Hcy, we hypothesize that system b 0,ϩ can mediate the uptake of Hcy-S-Hg-S-Hcy in renal epithelial cells expressing this transport system. We tested this hypothesis by studying and characterizing the transport of Hg 2ϩ , when presented as Hcy-SHg-S-Hcy, in type II Madin-Darby canine kidney (MDCK) cells transfected stably with both subunits of system b 0,ϩ . These cells are a line of renal epithelial cells derived from the distal nephron of the dog and were used for the current experiments because they do not normally express b 0,ϩ AT or rBAT. Data from the present study indicate clearly that Hg 2ϩ , in the form of Hcy-S-Hg-S-Hcy, is indeed a transportable, toxic substrate of system b 0,ϩ . This study is also the first to provide direct molecular evidence for the participation of a specific amino acid transport system, namely system b 0,ϩ , in the absorptive transport of, and cellular intoxication by, Hcy-S-Hg-S-Hcy.
Materials and Methods

Tissue Culture
Stably transfected MDCK cells, strain II, expressing both subunits of system, b 0,ϩ , b 0,ϩ AT, and rBAT (b 0,ϩ AT-rBAT transfectants), were kindly provided by Dr. Franç ois Verrey (University of Zurich, Zurich, Switzerland) and were cultured as described previously. 9, 18 Briefly, cells were cultured in Dulbecco's modified Eagle's medium (Mediatech, Herndon, VA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Atlanta, GA), 100 U/ml penicillin, 100 g/ml streptomycin, 1% essential amino acids, 200 g/ml geneticin, and 150 g/ml hygromycin B (Invitrogen, Carlsbad, CA). Wild-type cells were cultured in the same media without geneticin or hygromycin B. Cells were passaged by dissociation in 0.25% trypsin (Invitrogen)/0.5 mmol/L ethylenediaminetetraacetic acid in phosphate-buffered saline. Cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 .
Evaluation of Transport
Uptake measurements were performed as described previously with minor changes. 9, 19, 20 Both, wild-type and transfected MDCK cells were seeded in 24-well plates at a density of 0.2 ϫ 10 6 cells/well and were cultured for 24 hours before the experiment. Transfectants were cultured in the presence of 1 mol/L dexamethasone to induce the expression of rBAT. 18 At the beginning of each experiment, culture media was aspirated and cells were washed with warm uptake buffer (25 mmol/L 4-(2-hy- 4 , and 5 mmol/L glucose, pH 7.5). Uptake was initiated by adding 250 l of uptake buffer containing radiolabeled substrates. Cells were incubated for 15 minutes at 37°C, unless otherwise stated. Uptake was terminated by aspiration of radiolabeled compounds followed by the addition of ice-cold uptake buffer containing 1 mmol/L sodium 2,3-dimercaptopropane-1-sulfonate (Sigma Chemical Co., St. Louis, MO), a well-known mercury chelator. 21 Cells were washed twice with 2,3-dimercaptopropane-1-sulfonate and were subsequently solubilized with 1% sodium dodecyl sulfate in 0.2 N NaOH. The cellular lysate was then added to 5 ml of Opti-Fluor scintillation cocktail (Packard Biosciences, Meriden, CT) and the radioactivity contained therein was determined by counting samples in a Beckman LS6500 scintillation counter (Beckmann Instruments, Fullerton, CA).
Hcy-S-Hg-S-Hcy was formed by incubating 5 mol/L HgCl 2 , containing 203 Hg 2ϩ , with 20 mol/L DL-homocysteine (Sigma Chemical Co.) for 10 minutes at room temperature. The ratio of these compounds ensured that each mercuric ion in solution bonded to the sulfur atom of two molecules of the respective thiol in a linear II coordinate covalent manner. The mercuric conjugates of thiolcontaining molecules formed under these conditions have been shown to be thermodynamically stable from a pH of 1 to 14.
22
Transport of Hg 2ϩ , in the form of Hcy-S-Hg-S-Hcy, was characterized under various conditions. Time-course experiments were performed wherein both transfectants and wild-type cells were incubated with 5 mol/L Hcy-SHg-S-Hcy, containing 203 Hg 2ϩ , for various periods ranging from 5 to 90 minutes. The saturation kinetics for the transport processes were determined by incubating cells with Hcy-S-Hg-S-Hcy, containing 203 Hg 2ϩ , for 15 minutes at 37°C in the presence of unlabeled Hcy-S-Hg-S-Hcy (1, 5, 10, 15, 25, 50 , 100 mol/L). The maximum velocity (V max ) and Michealis-Menten constant (K m ) were calculated using the following formula:
, where v ϭ velocity of transport and [S] ϭ substrate concentration. The temperature dependence for the uptake of Hg 2ϩ , in the form of Hcy-S-Hg-S-Hcy, was assessed by measuring the uptake of Hg 2ϩ at 4°C and 37°C in the presence of unlabeled Hcy-S-Hg-S-Hcy (1, 5, 10, 15, 25, 50 mol/L). Substrate specificity for the uptake of Hg 2ϩ was assessed by incubating cells with Hcy-S-Hg-S-Hcy, containing 203 Hg 2ϩ , for 15 minutes at 37°C in the presence of amino acids that are substrates of system b 0,ϩ (cystine, Hcy, arginine, leucine, histidine, phenylalanine, lysine, or cycloleucine) or amino acids that are not substrates of this system (glutamate or aspartate). With the exception of cystine, all amino acids were used at a concentration of 3 mmol/L. Because of low solubility, the highest attainable concentration of cystine was 1 mmol/L.
As a negative control, cells were exposed to 5 mol/L Hg 2ϩ in the presence of 20 mol/L GSH, which promotes the formation of the mercuric conjugate of GSH, G-S-Hg-S-G. Incubation with Cys-S-Hg-S-Cys served as a positive control. These conjugates were formed as described previously for Hcy-S-Hg-S-Hcy. Wild-type and transfected cells were incubated with each conjugate for 30 minutes at 37°C.
To test the ability of Hg 2ϩ to bind to competing thiolcontaining molecules, cells were incubated with 5 mol/L Hcy-S-Hg-S-Hcy in the presence of increasing concentrations of GSH (1 to 50 mol/L). The incubation was performed for 30 minutes at 37°C.
Cystine Efflux Assays
The ability of Hcy-S-Hg-S-Hcy to stimulate the efflux of cystine was measured in wild-type cells and b 0,ϩ AT-rBAT transfectants. Cells were exposed to 1 mmol/L cystine, containing [
35 S]-cystine, for 10 minutes at 37°C. Extracellular cystine was aspirated and the cells were washed with warm uptake buffer. To measure the effects of various compounds on the efflux of [
35 S]-cystine/Cys (some of the cystine may have been reduced intracellularly), cells were incubated for 1 minute at 37°C with either uptake buffer, 1 mmol/L unlabeled cystine, Cys-S-Hg-SCys, Hcy-S-Hg-S-Hcy, or homocystine. After this incubation, the extracellular fluid was removed and placed in vials containing 5 ml of Opti-Fluor scintillation cocktail. The [
35 S] contained therein was measured using standard methods for liquid scintillation spectrometry. Cells were then washed twice with ice-cold buffer and were solubilized using 1% sodium dodecyl sulfate/0.2 N NaOH. The cellular content of [
35 S] was determined by liquid scintillation spectrometry.
Assessment of Cellular Viability
The toxicological effects of Hg 2ϩ , in the form of Hcy-SHg-S-Hcy, were quantified using a methylthiazoletetrazolium (MTT) assay as described previously. 9, 23 This assay measures the activity of mitochondrial dehydrogenase via the conversion of MTT (Sigma Chemical Co.) to formazan crystals. Wild-type and transfected MDCK cells were seeded at a density of 0.2 ϫ 10 6 cells/ml in 96-well culture dishes (200 l/well). Cells were cultured for 24 hours, washed twice with warm uptake buffer, and then treated with Hcy-S-Hg-S-Hcy (100, 250, 500, 750, or 1000 mol/L) in uptake buffer containing glutamine. The incubation was performed for 14 hours at 37°C in a humidified atmosphere of 5% CO 2 . Subsequently, cells were washed twice with warm uptake buffer and incubated in MTT (0.5 mg/ml) for 2 hours at 37°C in a humidified atmosphere containing 5% CO 2 . After this incubation, solubilization buffer (10% Triton X-100, 0.1 N HCl in isopropyl alcohol) was added to each well and the mixture was allowed to incubate for 16 hours at room temperature. Each plate was read at 490 nm in a BioTek Quant spectrophotometric plate reader (BioTek, Winooski, VT).
Morphologically discernable pathological changes in the transfected and wild-type MDCK II cells exposed to Hcy-S-Hg-S-Hcy were also characterized and semiquantified microscopically. Wild-type and transfected MDCK cells were seeded in chambered coverslips (Nalge Nunc, Naperville, IL) at a density of 0.2 ϫ 10 6 cells/ml (0.5 ml/chamber). Cells were treated with various concentrations of Hcy-S-Hg-S-Hcy in uptake buffer containing glutamine. This incubation was performed for 14 hours at 37°C. After the exposure to Hcy-S-Hg-S-Hcy, cells were washed with buffer and the culture media was returned to the chamber. Microscopic images were captured immediately using an Olympus IX-70 inverted biological microscope (Olympus, Melville, NY) equipped with Normarsky optics (Nikon, Melville, NY). All observations of cells were performed using ϫ10 eyepieces and a ϫ20 planfluor objective. Images were captured with a Nikon DXM 1200 digital camera.
Data Analysis
All transport experiments were repeated at least three times and each measurement was performed in quadruplicate. Data are presented as mean Ϯ SE. Data expressed as a percent were first normalized using the arcsine transformation before applying any parametric statistical analysis. This transformation takes the arcsine of the square root of the decimal fraction of the percent score. Data for each parameter assessed were first analyzed for normality and for homogeneity of variance. After determining that the data for each parameter were distributed normally with the Kolmogorov-Smirnov test and that there was equal variance among the groups of data using the Levene's test, the means for each set of data were evaluated with a two-way analysis of variance. When statistically significant F-values were obtained with the analysis of variance, Tukey's multiple comparison posthoc procedure was used to assess differences among the means. A P value of Ͻ0.05 was considered statistically significant.
Results
Transport of Hg 2ϩ (as Hcy-S-Hg-S-Hcy)
Time-course analyses show that there was time-dependent uptake of Hg 2ϩ in both the wild-type cells and the b 0,ϩ ATrBAT transfectants exposed to 5 mol/L Hcy-S-Hg-S-Hcy ( Figure 1A ). However, with the exception of the 5-minute time point, the level of uptake of Hg 2ϩ in the transfectants was significantly greater than that of the wild-type cells at all times studied.
The saturation kinetics for the uptake of Hg 2ϩ during the exposure to Hcy-S-Hg-S-Hcy were analyzed in wildtype and b 0,ϩ AT-rBAT-transfected cells ( Figure 1B) . Concentration-dependent uptake of Hg 2ϩ during the exposure to Hcy-S-Hg-S-Hcy was significantly greater in the b 0,ϩ AT-rBAT transfectants than in the wild-type cells. In the transfectants, the estimated V max for transport was 60.8 Ϯ 7.0 pmol ϫ mg protein Ϫ1 ϫ minute Ϫ1 , whereas the K m was calculated to be 144.4 Ϯ 24.8 mol/L.
Temperature-dependent uptake of Hg 2ϩ was detected only in the b 0,ϩ AT-rBAT transfectants exposed to Hcy-SHg-S-Hcy (Figure 2 ). At 37°C, the uptake of Hg 2ϩ , as Hcy-S-Hg-S-Hcy, was significantly greater in the transfectants than in the corresponding groups of wild-type cells. Furthermore, the amount of transport in the transfectants at 37°C was significantly greater than that observed at 4°C. When the experimental temperature was maintained at 4°C, the association of Hg 2ϩ with either cell type was minimal. There were no significant differences in the accumulation of Hg 2ϩ between corresponding groups of transfected and wild-type cells. Moreover, the amount of substrate associated with either cell type at 4°C was similar to that associated with wild-type cells at 37°C.
The findings obtained in the substrate specificity experiments for the transport of Hg 2ϩ , in the form of Hcy-S-Hg-S-Hcy, are presented in Figure 3 . In the transfected MDCK II cells exposed to Hcy-S-Hg-S-Hcy, the uptake of Hg 2ϩ was reduced significantly by the presence of unlabeled Hcy, arginine, leucine, histidine, phenylalanine, lysine, or cycloleucine. The amino acids, glutamate and aspartate, which are not substrates of system b 0,ϩ , did not significantly alter the transport of Hg 2ϩ . Interestingly, co-incubation of Hcy-S-Hg-S-Hcy with unlabeled cystine resulted in a twofold increase in the uptake of Hg 2ϩ in the transfected MDCK cells. This stimulation was also observed at lower concentrations of cystine ( Figure 4A ). Similarly, when the transport of Hg 2ϩ was measured in the presence of excess homocystine, uptake of Hg 2ϩ was stimulated ( Figure 4B ). Interestingly, this stimulation occurred in both wild-type and transfected cells.
Alternatively, when the uptake of [ 35 S]-cystine was measured in the presence of excess Hcy-S-Hg-S-Hcy, transport in the b 0,ϩ AT-rBAT-transfectants was inhibited ( Figure 5A ). The IC 50 (50% inhibition) for this process was calculated to be 37.2 Ϯ 7.9 mol/L. There were no significant differences among groups of wild-type cells. The uptake of other substrates for system b 0,ϩ , ie, [ 
Efflux Assays
Efflux assays were performed in wild-type cells and b 0,ϩ AT-rBAT transfectants to determine the ability of unlabeled cystine, Hcy-S-Hg-S-Hcy, Cys-S-Hg-S-Cys, or homocystine to stimulate the efflux of [
35 S]-cystine (Figure 6A ). Cells were preloaded with [
35 S]-cystine for 10 minutes at 37°C, after which the efflux of [
35 S] (the radiolabel may be in the form of cystine or Cys as some intracellular reduction may occur) was measured for 1 minute at 37°C in the presence of the aforementioned compounds. There were no significant differences in the efflux of cystine among the treatment groups of wild-type cells. In the transfectants, however, Hcy-S-Hg-S-Hcy, Cys-S-Hg-S-Cys, homocystine, and cystine stimulated the efflux of 35 S] was measured, the pattern of cystine uptake corresponded inversely to the pattern of cystine efflux described above, ie, the greater the efflux, the lower the cellular content of [
35 S] ( Figure 6B ).
Transport of Mercuric Conjugates of ThiolContaining Biological Molecules
The uptake of Hg 2ϩ , as a mercuric conjugate of Hcy (Hcy-S-Hg-S-Hcy), Cys (Cys-S-Hg-S-Cys), or GSH (G-SHg-S-G) was measured in wild-type cells and transfectants ( Figure 7A ). When the transfected cells were exposed to Hcy-S-Hg-S-Hcy, the uptake of Hg 2ϩ was threefold greater than that in the corresponding group of wild-type cells. Incubation with Cys-S-Hg-S-Cys resulted in a twofold increase in the uptake of Hg 2ϩ compared with that in the corresponding group of wild-type cells. When the cells were exposed to G-S-Hg-S-G, there were no significant differences in the uptake of Hg 2ϩ between corresponding groups of wild-type and transfected MDCK II cells. These data confirmed previously reported findings. 9 
Thiol Competition Assays
Thiol competition assays were performed to determine whether GSH was able to compete with Hcy to bind Hg 2ϩ . The formation of G-S-Hg-S-G was measured indirectly by incubating wild-type and b 0,ϩ AT-rBAT-transfected cells with Hg 2ϩ , as Hcy-S-Hg-S-Hcy, in the presence of increasing concentrations of GSH. As the GSH concentration increased, the amount of Hg 2ϩ taken up by the transfectants was reduced significantly. There were no significant differences in the accumulation of Hg 2ϩ among groups of wild-type cells ( Figure 7B ).
Cellular Viability Assays
To determine the relationship between cellular transport and intoxication, the cellular viability of wild-type and 0,ϩ AT-rBAT-transfectants. Cells were exposed to 1 mmol/L cystine, containing 35 S-cystine, for 10 minutes at 37°C and were subsequently incubated with buffer only, 1 mmol/L cystine, homocystine, or mercuric conjugates of Cys (Cys-S-Hg-S-Cys) or Hcy (Hcy-S-Hg-S-Hcy) for 1 minute at 37°C. Results are presented as mean Ϯ SE. Data represent three experiments performed in triplicate. *, Significantly different (P Ͻ 0.05) from the mean for the corresponding group of wild-type cells. ϩ, Significantly different from the mean for the group of transfectants exposed to buffer. ϩϩ, Significantly different from the mean for the transfectants exposed to buffer, cystine, or homocystine. ϩϩϩ, Significantly different from the mean for all other groups of transfected cells. transfected cells exposed to Hg 2ϩ was assessed. After a 14-hour exposure to 50 mol/L Hcy-S-Hg-S-Hcy, the viability of the b 0,ϩ AT-rBAT transfectants was reduced by 12%; exposure to 1 mmol/L Hcy-S-Hg-S-Hcy decreased viability by 85% (Figure 8 ). The cellular viability of the wild-type cells was decreased significantly (20%) only after exposure to 1 mmol/L Hcy-S-Hg-S-Hcy. Treatment with 5 mol/L Hcy-S-Hg-S-Hcy for 30 minutes (experimental conditions used to study various characteristics of transport) did not significantly reduce the cellular viability in either cell type (data not shown).
Morphological Assessment of Toxicity
The appearance of pathological changes was documented in wild-type and transfected cells exposed to various concentrations of Hg 2ϩ , as Hcy-S-Hg-S-Hcy. After a 14-hour exposure to 500 mol/L Hg 2ϩ , the wild-type cells were confluent and exhibited few discernable morphological changes (Figure 9 ). In contrast, after the Hg 2ϩ -exposure, the transfected cells were no longer confluent and many of the cells appeared spherical as they lost their attachments to the culture surface ( Figure 9 ). In addition, many cells contained large vacuoles and exhibited fragmented DNA.
Discussion
Inorganic mercury (Hg 2ϩ ) binds readily to thiol-containing biomolecules, such as GSH, Cys, and Hcy. These three thiols are present in plasma at similar concentrations (5 to 10 mol/L) and thus, may each bind Hg 2ϩ . Indeed, GSH and Cys have been implicated in the binding and subsequent transport of Hg 2ϩ . 21 Moreover, Cannon and colleagues 24, 25 have proposed that mercuric conjugates of Cys (Cys-S-Hg-S-Cys), which are similar structurally to the amino acid cystine, are taken up by cystine transporters via a mechanism of molecular mimicry. It is thought that Cys-S-Hg-S-Cys acts as a mimic of cystine at the site of these carriers. In fact, recent data from our laboratory indicate that, indeed, the cystine transporter, system b 0,ϩ , is involved in the luminal uptake of Cys-S-Hg-S-Cys in proximal tubular cells. 9 Although Hcy and Cys are in plasma at similar concentrations, 26 very little is known about the potential role of Hcy in the renal uptake of Hg 2ϩ . Given that Hcy is a structural homologue of Cys, it seems logical to hypothesize that this amino acid is involved in the handling and transport of Hg 2ϩ in the kidneys. In fact, previous in vivo data from our laboratory provided the first line of experimental evidence implicating Hcy-S-Hg-S-Hcy as a transportable substrate along the renal proximal tubule. 15 The actual mechanism(s) involved in this uptake, however, was/were not defined. Consequently, we tested the hypothesis that Hcy-S-Hg-S-Hcy, in addition to Cys-S-Hg-S- AT-rBAT-transfected cells revealed that the rate of uptake of this conjugate in the transfectants was at least twofold greater than that in the wildtype cells. Analysis of the saturation kinetics for the transport of Hcy-S-Hg-S-Hcy also showed a twofold increase in the magnitude of uptake of Hcy-S-Hg-S-Hcy in the transfectants compared with that in wild-type cells. Because the only apparent difference between the wild-type and transfected MDCK cells was the presence of a functional system b 0,ϩ transporter, it can be concluded that this transporter was responsible for the differences in transport between the two cell types studied. As a result, the findings obtained from the transfected cells indicate that Hcy-S-Hg-S-Hcy is indeed a transportable substrate of system b 0,ϩ and that this transporter is capable of mediating the absorptive uptake of this conjugate in vivo.
It should be mentioned that a small amount of Hg 2ϩ was associated with the wild-type cells when the cells were exposed to Hcy-S-Hg-S-Hcy. It is likely, however, that this association represents nonspecific binding and/or uptake via another mechanism. This conclusion is supported by our data showing temperature-dependent transport in only the transfectants. These data support the hypothesis that the uptake Hcy-S-Hg-S-Hcy in the transfectants is a carrier-mediated process. Substrate-specificity analyses of transport provide further support for the hypothesis that Hcy-S-Hg-S-Hcy is taken up by system b 0,ϩ . Substrates that are typically transported by system b 0,ϩ inhibited the transport of Hcy-S-Hg-S-Hcy whereas amino acids that are not substrates of this transporter did not affect the uptake of this conjugate. This pattern of inhibition parallels that observed when cystine 9, 18 or Cys-S-Hg-S-Cys, 9 were used as transportable substrates of system b 0,ϩ . Interestingly, when the uptake of Hcy-S-Hg-S-Hcy was assessed in the presence of unlabeled cystine or homocystine, inward transport of Hcy-S-Hg-S-Hcy was stimulated twofold or greater in the transfected cells. This stimulation was observed at all concentrations of cystine or homocystine studied. This phenomenon was specific for the substrate Hcy-S-Hg-S-Hcy because the transport of other substrates of system b 0,ϩ , such as [ 35 S]-cystine, [ 3 H]-arginine, or [ 3 H]-lysine was inhibited when each of these substrates was co-administered with unlabeled cystine or homocystine. One explanation for the observed stimulatory effect is that the presence of excess cystine or homocystine increases the rate of Hcy-S-Hg-S-Hcy uptake by some presently unknown exchange mechanism.
To test this theory, we studied the efflux of [ 35 S]-cystine/Cys (as some of the cystine may be reduced intracellularly) in wild-type and b 0,ϩ AT-rBAT-transfected MDCK cells pre-exposed to 1 mmol/L cystine, containing . Cystine and homocystine were also able to stimulate efflux, but to a lesser degree. The efflux of [ 35 S] from cells exposed to uptake buffer was significantly less than that in the cells exposed to other compounds. This efflux may represent the fraction of cystine that diffuses passively out of the cells. Although the implications for these data are unclear, the results indicate that there is a unique interaction between Hcy-S-Hg-S-Hcy and cystine, which promotes the uptake of this conjugate. A similar type of interaction has been shown to occur when Cys-S-Hg-S-Cys was used as a transportable substrate of system b 0,ϩ . 9 Pathophysiological measurements, in the form of MTT assays, and detailed microscopic analyses from the present study indicate that the amino acid transporter, system b 0,ϩ , plays a role in the cellular intoxication in- Figure 9 . Morphological analysis of wild-type (A) and b 0,ϩ AT-rBAT-transfected (B) MDCK II cells exposed to 500 mol/L inorganic mercury (Hg 2ϩ ), as a conjugate of Hcy (Hcy-S-Hg-S-Hcy), for 14 hours at 37°C. All observations of cells were performed using ϫ10 eyepieces and a ϫ20 planfluor objective. Images are representative of two separate experiments.
